Published in CNS Drugs on June 01, 2012
Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression. Biol Psychiatry (2014) 1.54
Neuroinflammation and psychiatric illness. J Neuroinflammation (2013) 1.42
Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun (2012) 1.18
Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J Neuroinflammation (2013) 1.08
Healthy aging diets other than the Mediterranean: a focus on the Okinawan diet. Mech Ageing Dev (2014) 0.91
Markers of Oxidative Stress and Neuroprogression in Depression Disorder. Oxid Med Cell Longev (2015) 0.88
Dietary patterns and the risk of depression in adults: a systematic review of observational studies. Eur J Nutr (2014) 0.88
Psychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy? Oxid Med Cell Longev (2015) 0.81
Evidence of higher oxidative status in depression and anxiety. Oxid Med Cell Longev (2014) 0.79
The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress. Oxid Med Cell Longev (2015) 0.78
Evaluation of Ajuga bracteosa for antioxidant, anti-inflammatory, analgesic, antidepressant and anticoagulant activities. BMC Complement Altern Med (2016) 0.77
Atypical antidepressants extend lifespan of Caenorhabditis elegans by activation of a non-cell-autonomous stress response. Aging Cell (2015) 0.77
Cocoa bioactive compounds: significance and potential for the maintenance of skin health. Nutrients (2014) 0.76
Effects of Antidepressants on DSP4/CPT-Induced DNA Damage Response in Neuroblastoma SH-SY5Y Cells. Neurotox Res (2015) 0.75
DNA Damage in Major Psychiatric Diseases. Neurotox Res (2016) 0.75
Evaluation of antidepressant-like effects of aqueous and ethanolic extracts of Pimpinella anisum fruit in mice. Avicenna J Phytomed (2016) 0.75
Associations between the antioxidant network and emotional intelligence: a preliminary study. PLoS One (2014) 0.75
1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous Neuroprotectant and MAO inhibitor with antidepressant-like properties in the rat. Neurotox Res (2013) 0.75
Protective and therapeutic potency of N-acetyl-cysteine on propionic acid-induced biochemical autistic features in rats. J Neuroinflammation (2013) 0.75
Decreased Total Antioxidant Activity in Major Depressive Disorder Patients Non-Responsive to Antidepressant Treatment. Psychiatry Investig (2016) 0.75
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. Br J Clin Pharmacol (2012) 1.62
Metal fume fever. Lancet (2013) 1.43
Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. J Biol Chem (2008) 1.30
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis. Pharmacol Res (2008) 1.27
Biosimilar drugs : concerns and opportunities. BioDrugs (2007) 1.26
Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Surv Ophthalmol (2002) 1.24
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Neuropsychopharmacology (2008) 1.21
The use of antidepressant drugs and the lifetime prevalence of major depressive disorders in Italy. Clin Pract Epidemiol Ment Health (2010) 1.20
Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. Eur J Pharmacol (2009) 1.16
Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. Learn Mem (2009) 1.16
Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity. Int J Endocrinol (2013) 1.16
Brown tumour in a patient with secondary hyperparathyroidism resistant to medical therapy: case report on successful treatment after subtotal parathyroidectomy. Int J Endocrinol (2009) 1.10
Curcumin and the cellular stress response in free radical-related diseases. Mol Nutr Food Res (2008) 1.06
Protective effects of a coumarin derivative in diabetic rats. Invest Ophthalmol Vis Sci (2009) 1.06
Isoflavones: estrogenic activity, biological effect and bioavailability. Eur J Drug Metab Pharmacokinet (2013) 1.05
TGF-beta 1 protects against Abeta-neurotoxicity via the phosphatidylinositol-3-kinase pathway. Neurobiol Dis (2008) 1.04
Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade. Eur J Pharmacol (2003) 1.03
Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression. Eur Neuropsychopharmacol (2010) 1.02
Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease. Int J Biochem Cell Biol (2012) 1.01
Potential role of probiotics on colorectal cancer prevention. BMC Surg (2012) 1.01
Home telemonitoring for patients with severe respiratory illness: the Italian experience. J Telemed Telecare (2003) 1.01
Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Biochem Pharmacol (2012) 0.99
Pharmacological management of ocular hypertension: current approaches and future prospective. Curr Opin Pharmacol (2012) 0.99
Simple determination of riluzole in rat brain by high-performance liquid chromatography and spectrophotometric detection. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.99
Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells. Pharmacol Res (2013) 0.98
Red orange: experimental models and epidemiological evidence of its benefits on human health. Oxid Med Cell Longev (2013) 0.98
The major green tea polyphenol, (-)-epigallocatechin-3-gallate, induces heme oxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress. J Am Coll Nutr (2009) 0.98
Mediterranean diet and cancer: epidemiological evidence and mechanism of selected aspects. BMC Surg (2013) 0.97
Natural antioxidants in Alzheimer's disease. Expert Opin Investig Drugs (2007) 0.97
Endocannabinoids and neurodegenerative diseases. Pharmacol Res (2007) 0.97
Sigma receptor ligands protect human retinal cells against oxidative stress. Neuroreport (2006) 0.97
TGF-β1 pathway as a new target for neuroprotection in Alzheimer's disease. CNS Neurosci Ther (2009) 0.96
Dysfunction of TGF-β1 signaling in Alzheimer's disease: perspectives for neuroprotection. Cell Tissue Res (2011) 0.95
Oxidative stress in normal-weight obese syndrome. Obesity (Silver Spring) (2010) 0.95
The lifetime prevalence of bipolar disorders and the use of antidepressant drugs in bipolar depression in Italy. J Affect Disord (2011) 0.95
Laparoscopic vs. open approach for colorectal cancer: evolution over time of minimal invasive surgery. BMC Surg (2013) 0.94
Endocannabinoid system and mood disorders: priming a target for new therapies. Pharmacol Ther (2012) 0.93
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. Front Behav Neurosci (2011) 0.93
Laparoscopic adjustable gastric bandings: a prospective randomized study of 400 operations performed with 2 different devices. Arch Surg (2007) 0.92
Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial. Pharmacol Res (2004) 0.92
Effect of chitinase inhibitors on endotoxin-induced uveitis (EIU) in rabbits. Pharmacol Res (2008) 0.92
High prevalence of celiac disease in patients with lactose intolerance. Digestion (2005) 0.91
Body composition changes and cardiometabolic benefits of a balanced Italian Mediterranean Diet in obese patients with metabolic syndrome. Acta Diabetol (2012) 0.91
The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression. Eur Neuropsychopharmacol (2011) 0.90
Chronic antidepressants induce redistribution and differential activation of alphaCaM kinase II between presynaptic compartments. Neuropsychopharmacology (2007) 0.90
Lipoprotein(a) serum levels in diabetic patients with retinopathy. Biomed Res Int (2013) 0.89
Elevated serum levels of Chromogranin A in hepatocellular carcinoma. BMC Surg (2012) 0.89
Prenatal stress alters glutamatergic system responsiveness in adult rat prefrontal cortex. J Neurochem (2009) 0.89
Effects of the COOH-terminal tripeptide alpha-MSH(11-13) on corneal epithelial wound healing: role of nitric oxide. Exp Eye Res (2006) 0.89
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation. PLoS One (2012) 0.89
Anandamide-induced behavioral disruption through a vanilloid-dependent mechanism in rats. Psychopharmacology (Berl) (2008) 0.88
Sub-threshold depression and antidepressants use in a community sample: searching anxiety and finding bipolar disorder. BMC Psychiatry (2011) 0.88
Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies. Biochem Pharmacol (2013) 0.88
Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extract. Curr Drug Metab (2011) 0.88
Quality of life and urban / rural living: preliminary results of a community survey in Italy. Clin Pract Epidemiol Ment Health (2012) 0.88
Spinach and tomato consumption increases lymphocyte DNA resistance to oxidative stress but this is not related to cell carotenoid concentrations. Eur J Nutr (2002) 0.88
Evaluation of four comorbidity indices and Charlson comorbidity index adjustment for colorectal cancer patients. Int J Colorectal Dis (2014) 0.88
Factors associated with colorectal cancer in the context of the Mediterranean diet: a case-control study. Nutr Cancer (2014) 0.87
Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs? Eur J Pharmacol (2007) 0.87
Evaluation of CHI3L-1 and CHIT-1 expression in differentiated and polarized macrophages. Inflammation (2013) 0.86
The role of neutrophils in corneal wound healing in HO-2 null mice. PLoS One (2011) 0.86
Dopamine-₃ receptor modulates intraocular pressure: implications for glaucoma. Biochem Pharmacol (2011) 0.86
Effects of neurosteroids on ischemia-reperfusion injury in the rat retina: role of sigma1 recognition sites. Eur J Pharmacol (2004) 0.86
-174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers. Pharmacogenet Genomics (2012) 0.86
Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 alpha and beta plasma levels. Pharmacol Res (2006) 0.86
Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST). Eur Neuropsychopharmacol (2007) 0.86
Six novel mutations in the proopiomelanocortin and melanocortin receptor 4 genes in severely obese adults living in southern Italy. Clin Chem (2005) 0.86
Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems. Pharmacol Res (2010) 0.85
Decreased concentration of adiponectin together with a selective reduction of its high molecular weight oligomers is involved in metabolic complications of myotonic dystrophy type 1. Eur J Endocrinol (2011) 0.85
Possible involvement of nitric oxide in morphine-induced miosis and reduction of intraocular pressure in rabbits. Eur J Pharmacol (2006) 0.85
Low levels of 17-β-oestradiol, oestrone and testosterone correlate with severe evaporative dysfunctional tear syndrome in postmenopausal women: a case-control study. Br J Ophthalmol (2014) 0.85
Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution. Nanomedicine (Lond) (2010) 0.84
Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test). Eur J Pharmacol (2005) 0.84
Dual-energy X-ray absorptiometry analysis of body composition in patients affected by OSAS. Eur Arch Otorhinolaryngol (2008) 0.84
Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line. World J Gastroenterol (2012) 0.84
Different Retinal Expression Patterns of IL-1α, IL-1β, and Their Receptors in a Rat Model of Type 1 STZ-Induced Diabetes. J Mol Neurosci (2015) 0.84
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia. Brain Res (2006) 0.83
Effects of PPARγ ligands on vascular tone. Curr Mol Pharmacol (2012) 0.83
Survey of the occurrence of Aflatoxin M1 in ovine milk by HPLC and its confirmation by MS. Mol Nutr Food Res (2006) 0.83
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems. Neurobiol Dis (2009) 0.83
Dopamine D(3) receptor as a new pharmacological target for the treatment of depression. Eur J Pharmacol (2013) 0.83
Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats. Peptides (2012) 0.83
Natalizumab: a country-based surveillance program. Neurol Sci (2008) 0.82
Endothelium-dependent vasomotor effects of telmisartan in isolated rat femoral arteries. Pharmacol Res (2010) 0.82
Acidic Mammalian chitinase and the eye: implications for ocular inflammatory diseases. Front Pharmacol (2011) 0.82
Ocular pharmacokinetics profile of different indomethacin topical formulations. J Ocul Pharmacol Ther (2011) 0.82
Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits. Int J Pharm (2012) 0.82
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy. J Diabetes Res (2013) 0.82
Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.82
Binge-like eating in mice. Int J Eat Disord (2009) 0.82
The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats. Eur J Pharmacol (2012) 0.82
Pericentrin expression in Down's syndrome. Neurol Sci (2013) 0.82
Long-term exposure to the atypical antipsychotic olanzapine differently up-regulates extracellular signal-regulated kinases 1 and 2 phosphorylation in subcellular compartments of rat prefrontal cortex. Mol Pharmacol (2006) 0.81
Adiponectin as novel regulator of cell proliferation in human glioblastoma. J Cell Physiol (2014) 0.81
Melatonin affects the immobility time of rats in the forced swim test: the role of serotonin neurotransmission. Eur Neuropsychopharmacol (2006) 0.81
The mtDNA 15497 G/A polymorphism in cytochrome b in severe obese subjects from Southern Italy. Nutr Metab Cardiovasc Dis (2005) 0.81
Hyaluronan-induced stimulation of corneal wound healing is a pure pharmacological effect. J Ocul Pharmacol Ther (2004) 0.81
Bioactive Compounds of Aristotelia chilensis Stuntz and their Pharmacological Effects. Curr Pharm Biotechnol (2016) 0.81